Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 256 articles:
HTML format
Text format



Single Articles


    January 2017
  1. ZHANG S, Deng Z, Yao C, Huang P, et al
    AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms.
    PLoS One. 2017;12:e0169585.
    PubMed     Text format     Abstract available


  2. HUANG WS, Kuo YH, Kuo HC, Hsieh MC, et al
    CIL-102-Induced Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells via Upregulation of p21 and GADD45.
    PLoS One. 2017;12:e0168989.
    PubMed     Text format     Abstract available


  3. LU M, Zessin AS, Glover W, Hsu DS, et al
    Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
    PLoS One. 2017;12:e0169439.
    PubMed     Text format     Abstract available


  4. WU R, Feng J, Yang Y, Dai C, et al
    Significance of Serum Total Oxidant/Antioxidant Status in Patients with Colorectal Cancer.
    PLoS One. 2017;12:e0170003.
    PubMed     Text format     Abstract available


  5. LI Y, Wang WY, Xiao JH, Xu F, et al
    Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.
    PLoS One. 2017;12:e0167868.
    PubMed     Text format     Abstract available


  6. FROUWS MA, Reimers MS, Swets M, Bastiaannet E, et al
    The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.
    PLoS One. 2017;12:e0170775.
    PubMed     Text format     Abstract available


  7. QIN M, Zhang J, Xu C, Peng P, et al
    Knockdown of NIK and IKKbeta-Binding Protein (NIBP) Reduces Colorectal Cancer Metastasis through Down-Regulation of the Canonical NF-kappaBeta Signaling Pathway and Suppression of MAPK Signaling Mediated through ERK and JNK.
    PLoS One. 2017;12:e0170595.
    PubMed     Text format     Abstract available


  8. SOO HC, Chung FF, Lim KH, Yap VA, et al
    Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway.
    PLoS One. 2017;12:e0170551.
    PubMed     Text format     Abstract available


  9. KINAR Y, Akiva P, Choman E, Kariv R, et al
    Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer.
    PLoS One. 2017;12:e0171759.
    PubMed     Text format     Abstract available


  10. PENG Y, Yang H, Ye Q, Zhou H, et al
    Inhibition of peritoneal dissemination of colon cancer by hyperthermic CO2 insufflation: A novel approach to prevent intraperitoneal tumor spread.
    PLoS One. 2017;12:e0172097.
    PubMed     Text format     Abstract available


  11. ZHAI H, Shi Y, Chen X, Wang J, et al
    CacyBP/SIP promotes the proliferation of colon cancer cells.
    PLoS One. 2017;12:e0169959.
    PubMed     Text format     Abstract available


  12. FAN G, Zhang K, Yang X, Ding J, et al
    Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
    PLoS One. 2017;12:e0171991.
    PubMed     Text format     Abstract available


  13. ALI H, Bitar MS, Al Madhoun A, Marafie M, et al
    Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer.
    PLoS One. 2017;12:e0171690.
    PubMed     Text format     Abstract available


  14. ZERIOUH W, Nani A, Belarbi M, Dumont A, et al
    Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway.
    PLoS One. 2017;12:e0170823.
    PubMed     Text format     Abstract available


  15. LI P, Xiao Z, Braciak TA, Ou Q, et al
    A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    PLoS One. 2017;12:e0172799.
    PubMed     Text format     Abstract available


  16. PRIETO I, Del Puerto-Nevado L, Gonzalez N, Portal-Nunez S, et al
    Colon cancer modulation by a diabetic environment: A single institutional experience.
    PLoS One. 2017;12:e0172300.
    PubMed     Text format     Abstract available


  17. KATHER JN, Zollner FG, Schad LR, Melchers SM, et al
    Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0171378.
    PubMed     Text format     Abstract available


  18. WEBER L, Al-Refae K, Ebbert J, Jagers P, et al
    Activation of odorant receptor in colorectal cancer cells leads to inhibition of cell proliferation and apoptosis.
    PLoS One. 2017;12:e0172491.
    PubMed     Text format     Abstract available


  19. SARSHEKEH AM, Advani S, Overman MJ, Manyam G, et al
    Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
    PLoS One. 2017;12:e0173345.
    PubMed     Text format     Abstract available


  20. THEAN LF, Wong YH, Lo M, Loi C, et al
    Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to FAP-like phenotype in APC mutation-negative familial colorectal cancer patients.
    PLoS One. 2017;12:e0173772.
    PubMed     Text format     Abstract available


  21. TASHIRO T, Okuyama H, Endo H, Kawada K, et al
    In vivo and ex vivo cetuximab sensitivity assay using three-dimensional primary culture system to stratify KRAS mutant colorectal cancer.
    PLoS One. 2017;12:e0174151.
    PubMed     Text format     Abstract available


  22. GOEDE SL, Rabeneck L, van Ballegooijen M, Zauber AG, et al
    Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
    PLoS One. 2017;12:e0172864.
    PubMed     Text format     Abstract available


  23. CARLSON GE, Martin EW, Shirure VS, Malgor R, et al
    Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues.
    PLoS One. 2017;12:e0173747.
    PubMed     Text format     Abstract available


  24. SHINKINS B, Nicholson BD, Primrose J, Perera R, et al
    The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
    PLoS One. 2017;12:e0171810.
    PubMed     Text format     Abstract available


  25. SIMICZYJEW A, Mazur AJ, Dratkiewicz E, Nowak D, et al
    Involvement of beta- and gamma-actin isoforms in actin cytoskeleton organization and migration abilities of bleb-forming human colon cancer cells.
    PLoS One. 2017;12:e0173709.
    PubMed     Text format     Abstract available


  26. HUANG WY, Ho CL, Lee CC, Hsiao CW, et al
    Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.
    PLoS One. 2017;12:e0174280.
    PubMed     Text format     Abstract available


  27. YANG M, Xiao X, Xing X, Li X, et al
    KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer.
    PLoS One. 2017;12:e0174140.
    PubMed     Text format     Abstract available


  28. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    PubMed     Text format     Abstract available


  29. BERGER AW, Schwerdel D, Welz H, Marienfeld R, et al
    Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.
    PLoS One. 2017;12:e0174308.
    PubMed     Text format     Abstract available


  30. NAGAPPAN A, Lee WS, Yun JW, Lu JN, et al
    Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
    PLoS One. 2017;12:e0174591.
    PubMed     Text format     Abstract available


  31. ANDRES-FRANCH M, Galiana A, Sanchez-Hellin V, Ochoa E, et al
    Streptococcus gallolyticus infection in colorectal cancer and association with biological and clinical factors.
    PLoS One. 2017;12:e0174305.
    PubMed     Text format     Abstract available


  32. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
    Correction: Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    PLoS One. 2017;12:e0175659.
    PubMed     Text format     Abstract available


  33. ZHOU Y, Zhang X, Zhang J, Fang J, et al
    LRG1 promotes proliferation and inhibits apoptosis in colorectal cancer cells via RUNX1 activation.
    PLoS One. 2017;12:e0175122.
    PubMed     Text format     Abstract available


  34. CARVALHO AC, Leal F, Sasse AD
    Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.
    PLoS One. 2017;12:e0175409.
    PubMed     Text format     Abstract available


  35. BURMEISTER K, Quagliata L, Andreozzi M, Eppenberger-Castori S, et al
    Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes.
    PLoS One. 2017;12:e0175563.
    PubMed     Text format     Abstract available


  36. CAO G, Cheng D, Ye L, Pan Y, et al
    Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences.
    PLoS One. 2017;12:e0175284.
    PubMed     Text format     Abstract available


  37. ZERIOUH W, Nani A, Belarbi M, Dumont A, et al
    Correction: Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway.
    PLoS One. 2017;12:e0176574.
    PubMed     Text format     Abstract available


  38. ZHU B, Wu X, Wu B, Pei D, et al
    The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies.
    PLoS One. 2017;12:e0176068.
    PubMed     Text format     Abstract available


  39. BAILEY KL, Agarwal E, Chowdhury S, Luo J, et al
    TGFbeta/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells.
    PLoS One. 2017;12:e0176096.
    PubMed     Text format     Abstract available


  40. SHARMA A, Vatapalli R, Abdelfatah E, Wyatt McMahon K, et al
    Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.
    PLoS One. 2017;12:e0176139.
    PubMed     Text format     Abstract available


  41. KIM HJ, Jo MJ, Kim BR, Kim JL, et al
    Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.
    PLoS One. 2017;12:e0176834.
    PubMed     Text format     Abstract available


  42. SHIN SJ, Chun SM, Kim TI, Kim YJ, et al
    Feasibility of multiplexed gene mutation detection in plasma samples of colorectal cancer patients by mass spectrometric genotyping.
    PLoS One. 2017;12:e0176340.
    PubMed     Text format     Abstract available


  43. PEREYRA D, Offensperger F, Klinglmueller F, Haegele S, et al
    Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.
    PLoS One. 2017;12:e0175359.
    PubMed     Text format     Abstract available


  44. LI Y, Li J, Liu H, Liu Y, et al
    Expression of MYSM1 is associated with tumor progression in colorectal cancer.
    PLoS One. 2017;12:e0177235.
    PubMed     Text format     Abstract available


  45. LAKATOS E, Salehi-Reyhani A, Barclay M, Stumpf MPH, et al
    Protein degradation rate is the dominant mechanism accounting for the differences in protein abundance of basal p53 in a human breast and colorectal cancer cell line.
    PLoS One. 2017;12:e0177336.
    PubMed     Text format     Abstract available



  46. Correction: Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0177586.
    PubMed     Text format     Abstract available


  47. PRIETO V, Ludwig JM, Farris AB, Nagaraju GP, et al
    Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study.
    PLoS One. 2017;12:e0177212.
    PubMed     Text format     Abstract available


  48. LEE JY, Lee MK, Kim NK, Chu SH, et al
    Serum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study.
    PLoS One. 2017;12:e0176929.
    PubMed     Text format     Abstract available



  49. Correction: Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
    PLoS One. 2017;12:e0178275.
    PubMed     Text format     Abstract available


  50. GONZALEZ-DONQUILES C, Alonso-Molero J, Fernandez-Villa T, Vilorio-Marques L, et al
    The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review.
    PLoS One. 2017;12:e0177549.
    PubMed     Text format     Abstract available


  51. PARK JY, Kim SH, Lee SM, Lee JS, et al
    CT volumetric measurement of colorectal cancer helps predict tumor staging and prognosis.
    PLoS One. 2017;12:e0178522.
    PubMed     Text format     Abstract available


  52. LI J, Li Y, Liu H, Liu Y, et al
    The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.
    PLoS One. 2017;12:e0178515.
    PubMed     Text format     Abstract available


  53. OSUMI H, Shinozaki E, Suenaga M, Wakatsuki T, et al
    Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer.
    PLoS One. 2017;12:e0176745.
    PubMed     Text format     Abstract available


  54. KNUDSEN KN, Lindebjerg J, Nielsen BS, Hansen TF, et al
    MicroRNA-200b is downregulated in colon cancer budding cells.
    PLoS One. 2017;12:e0178564.
    PubMed     Text format     Abstract available


  55. HAN EC, Ryoo SB, Park JW, Yi JW, et al
    Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.
    PLoS One. 2017;12:e0178920.
    PubMed     Text format     Abstract available


  56. GAO B, Yu T, Xue D, Sun B, et al
    A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis.
    PLoS One. 2017;12:e0178760.
    PubMed     Text format     Abstract available


  57. BURON A, Auge JM, Sala M, Roman M, et al
    Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.
    PLoS One. 2017;12:e0179864.
    PubMed     Text format     Abstract available


  58. WANG J, Du S, Wang J, Fan W, et al
    The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0179670.
    PubMed     Text format     Abstract available


  59. ZHANG Z, Chang Y, Zhang J, Lu Y, et al
    HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/beta-catenin pathway.
    PLoS One. 2017;12:e0179741.
    PubMed     Text format     Abstract available


  60. KIM EK, Cho JH, Kim E, Kim YJ, et al
    Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth.
    PLoS One. 2017;12:e0181183.
    PubMed     Text format     Abstract available


  61. LOPES-RAMOS CM, Barros BP, Koyama FC, Carpinetti PA, et al
    E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancer.
    PLoS One. 2017;12:e0181153.
    PubMed     Text format     Abstract available


  62. RASMUSSEN SL, Krarup HB, Sunesen KG, Johansen MB, et al
    Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
    PLoS One. 2017;12:e0180809.
    PubMed     Text format     Abstract available


  63. POTOCNIK N, Perse M, Cerar A, Injac R, et al
    Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
    PLoS One. 2017;12:e0181632.
    PubMed     Text format     Abstract available


  64. URIBE DJ, Mandell EK, Watson A, Martinez JD, et al
    The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
    PLoS One. 2017;12:e0179979.
    PubMed     Text format     Abstract available


  65. LOCK FE, Babaian A, Zhang Y, Gagnier L, et al
    A novel isoform of IL-33 revealed by screening for transposable element promoted genes in human colorectal cancer.
    PLoS One. 2017;12:e0180659.
    PubMed     Text format     Abstract available


  66. MAKONDI PT, Chu CM, Wei PL, Chang YJ, et al
    Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
    PLoS One. 2017;12:e0180616.
    PubMed     Text format     Abstract available


  67. ZHANG Y, Liu H, Li L, Ai M, et al
    Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.
    PLoS One. 2017;12:e0181852.
    PubMed     Text format     Abstract available


  68. SIESING C, Sorbye H, Dragomir A, Pfeiffer P, et al
    High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
    PLoS One. 2017;12:e0182512.
    PubMed     Text format     Abstract available


  69. CHOI YR, Kim JH, Park SJ, Hur BY, et al
    Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images.
    PLoS One. 2017;12:e0182596.
    PubMed     Text format     Abstract available


  70. KUTUK O, Aytan N, Karakas B, Kurt AG, et al
    Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells.
    PLoS One. 2017;12:e0182809.
    PubMed     Text format     Abstract available


  71. LI Q, Wang Y, Lai Y, Xu P, et al
    HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling.
    PLoS One. 2017;12:e0182588.
    PubMed     Text format     Abstract available


  72. GLISZCZYNSKA A, Niezgoda N, Gladkowski W, Switalska M, et al
    Isoprenoid-phospholipid conjugates as potential therapeutic agents: Synthesis, characterization and antiproliferative studies.
    PLoS One. 2017;12:e0172238.
    PubMed     Text format     Abstract available


  73. GLADILIN E
    Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks.
    PLoS One. 2017;12:e0170953.
    PubMed     Text format     Abstract available


  74. HENLEY AB, Yang L, Chuang KL, Sahuri-Arisoylu M, et al
    Withania somnifera Root Extract Enhances Chemotherapy through 'Priming'.
    PLoS One. 2017;12:e0170917.
    PubMed     Text format     Abstract available


  75. ALSUBAIE N, Trahearn N, Raza SE, Snead D, et al
    Stain Deconvolution Using Statistical Analysis of Multi-Resolution Stain Colour Representation.
    PLoS One. 2017;12:e0169875.
    PubMed     Text format     Abstract available


  76. YOUNS M, Abdel Halim Hegazy W
    The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
    PLoS One. 2017;12:e0169335.
    PubMed     Text format     Abstract available


  77. ALMASUD AA, Giles KH, Miklavcic JJ, Martins KJB, et al
    Fish oil mitigates myosteatosis and improves chemotherapy efficacy in a preclinical model of colon cancer.
    PLoS One. 2017;12:e0183576.
    PubMed     Text format     Abstract available


  78. PELLINO G, Simillis C, Qiu S, Rasheed S, et al
    Social media and colorectal cancer: A systematic review of available resources.
    PLoS One. 2017;12:e0183031.
    PubMed     Text format     Abstract available


  79. KASHIWAGI K, Inoue N, Yoshida T, Bessyo R, et al
    Polyp detection rate in transverse and sigmoid colon significantly increases with longer withdrawal time during screening colonoscopy.
    PLoS One. 2017;12:e0174155.
    PubMed     Text format     Abstract available


  80. OTTERPOHL KL, Gould KA
    Evaluation of Rint1 as a modifier of intestinal tumorigenesis and cancer risk.
    PLoS One. 2017;12:e0172247.
    PubMed     Text format     Abstract available


  81. ZHAO J, Salomon MP, Shibata D, Curtis C, et al
    Early mutation bursts in colorectal tumors.
    PLoS One. 2017;12:e0172516.
    PubMed     Text format     Abstract available


  82. LEWITOWICZ P, Gluszek S, Koziel D, Horecka-Lewitowicz A, et al
    Conventional colon adenomas harbor various disturbances in microsatellite stability and contain micro-serrated foci with microsatellite instability.
    PLoS One. 2017;12:e0172381.
    PubMed     Text format     Abstract available


  83. ARSIC N, Ho-Pun-Cheung A, Evelyne C, Assenat E, et al
    The p53 isoform delta133p53ss regulates cancer cell apoptosis in a RhoB-dependent manner.
    PLoS One. 2017;12:e0172125.
    PubMed     Text format     Abstract available


  84. LIEDER B, Hoi JK, Holik AK, Geissler K, et al
    The flavanone homoeriodictyol increases SGLT-1-mediated glucose uptake but decreases serotonin release in differentiated Caco-2 cells.
    PLoS One. 2017;12:e0171580.
    PubMed     Text format     Abstract available


  85. FASTERIUS E, Raso C, Kennedy S, Rauch N, et al
    A novel RNA sequencing data analysis method for cell line authentication.
    PLoS One. 2017;12:e0171435.
    PubMed     Text format     Abstract available


  86. KIM KH, Yeo SG, Yoo BC, Myung JK, et al
    Identification of calgranulin B interacting proteins and network analysis in gastrointestinal cancer cells.
    PLoS One. 2017;12:e0171232.
    PubMed     Text format     Abstract available


  87. PURCELL RV, Pearson J, Aitchison A, Dixon L, et al
    Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia.
    PLoS One. 2017;12:e0171602.
    PubMed     Text format     Abstract available


  88. HUANG TC, Lee PT, Wu MH, Huang CC, et al
    Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells.
    PLoS One. 2017;12:e0181034.
    PubMed     Text format     Abstract available


  89. QI L, Zhang W, Cheng Z, Tang N, et al
    Study on molecular mechanism of ANOS1 promoting development of colorectal cancer.
    PLoS One. 2017;12:e0182964.
    PubMed     Text format     Abstract available


  90. PEREIRA AAL, Morelli MP, Overman M, Kee B, et al
    Clinical utility of circulating cell-free DNA in advanced colorectal cancer.
    PLoS One. 2017;12:e0183949.
    PubMed     Text format     Abstract available


  91. KOIRE A, Kim YW, Wang J, Katsonis P, et al
    Codon-level co-occurrences of germline variants and somatic mutations in cancer are rare but often lead to incorrect variant annotation and underestimated impact prediction.
    PLoS One. 2017;12:e0174766.
    PubMed     Text format     Abstract available


  92. HUA Y, Ma X, Liu X, Yuan X, et al
    Abnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinoma.
    PLoS One. 2017;12:e0174461.
    PubMed     Text format     Abstract available


  93. THORVALDSEN TE, Pedersen NM, Wenzel EM, Stenmark H, et al
    Differential Roles of AXIN1 and AXIN2 in Tankyrase Inhibitor-Induced Formation of Degradasomes and beta-Catenin Degradation.
    PLoS One. 2017;12:e0170508.
    PubMed     Text format     Abstract available


  94. ROSSI E, Bizzarro T, Martini M, Longatto-Filho A, et al
    The Role of Liquid Based Cytology and Ancillary Techniques in the Peritoneal Washing Analysis: Our Institutional Experience.
    PLoS One. 2017;12:e0168625.
    PubMed     Text format     Abstract available


  95. JEPPESEN M, Hagel G, Glenthoj A, Vainer B, et al
    Short-term spheroid culture of primary colorectal cancer cells as an in vitro model for personalizing cancer medicine.
    PLoS One. 2017;12:e0183074.
    PubMed     Text format     Abstract available


  96. HANKINS SC, Brimhall BB, Kankanala V, Austin GL, et al
    A low-volume polyethylene glycol solution was associated with an increased suboptimal bowel preparation rate but had similar recommendations for an early repeat colonoscopy, procedure times, and adenoma detection rates.
    PLoS One. 2017;12:e0176265.
    PubMed     Text format     Abstract available


  97. STEPPELER C, Sodring M, Egelandsdal B, Kirkhus B, et al
    Effects of dietary beef, pork, chicken and salmon on intestinal carcinogenesis in A/J Min/+ mice.
    PLoS One. 2017;12:e0176001.
    PubMed     Text format     Abstract available


  98. LAHTI S, Ludwig JM, Xing M, Sun L, et al
    In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study.
    PLoS One. 2017;12:e0174539.
    PubMed     Text format     Abstract available


  99. ISHIGURO S, Uppalapati D, Goldsmith Z, Robertson D, et al
    Exopolysaccharides extracted from Parachlorella kessleri inhibit colon carcinoma growth in mice via stimulation of host antitumor immune responses.
    PLoS One. 2017;12:e0175064.
    PubMed     Text format     Abstract available


  100. BINDER GALLIMIDI A, Nussbaum G, Hermano E, Weizman B, et al
    Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma.
    PLoS One. 2017;12:e0174343.
    PubMed     Text format     Abstract available


  101. SIEBENKAS C, Chiappinelli KB, Guzzetta AA, Sharma A, et al
    Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.
    PLoS One. 2017;12:e0179501.
    PubMed     Text format     Abstract available


  102. BOOT A, Oosting J, van Eendenburg JDH, Kuppen PJK, et al
    Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
    PLoS One. 2017;12:e0184900.
    PubMed     Text format     Abstract available


  103. ZHAN Z, Verberne CJ, van den Heuvel ER, Grossmann I, et al
    Psychological effects of the intensified follow-up of the CEAwatch trial after treatment for colorectal cancer.
    PLoS One. 2017;12:e0184740.
    PubMed     Text format     Abstract available


  104. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    PubMed     Text format     Abstract available


  105. WANG B, Yang J, Li S, Lv M, et al
    Tumor location as a novel high risk parameter for stage II colorectal cancers.
    PLoS One. 2017;12:e0179910.
    PubMed     Text format     Abstract available


  106. KURACHA MR, Thomas P, Loggie BW, Govindarajan V, et al
    Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies.
    PLoS One. 2017;12:e0179510.
    PubMed     Text format     Abstract available


  107. LI Z, Li SA, Sun Y, Liu Y, et al
    TNF-alpha -308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China.
    PLoS One. 2017;12:e0178218.
    PubMed     Text format     Abstract available


  108. IWATA T, Uchino T, Koyama A, Johmura Y, et al
    The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
    PLoS One. 2017;12:e0178221.
    PubMed     Text format     Abstract available


  109. PENG YC, Lin CL, Sung FC
    The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.
    PLoS One. 2017;12:e0177745.
    PubMed     Text format     Abstract available


  110. LAMBERTI MJ, Pansa MF, Vera RE, Fernandez-Zapico ME, et al
    Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy.
    PLoS One. 2017;12:e0177801.
    PubMed     Text format     Abstract available


  111. DE WIT M, Carvalho B, Delis-van Diemen PM, van Alphen C, et al
    Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
    PLoS One. 2017;12:e0174768.
    PubMed     Text format     Abstract available


  112. COEBERGH VAN DEN BRAAK RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, et al
    High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
    PLoS One. 2017;12:e0185607.
    PubMed     Text format     Abstract available


  113. NIIKURA R, Hirata Y, Suzuki N, Yamada A, et al
    Colonoscopy reduces colorectal cancer mortality: A multicenter, long-term, colonoscopy-based cohort study.
    PLoS One. 2017;12:e0185294.
    PubMed     Text format     Abstract available


  114. SLIK K, Kurki S, Korpela T, Carpen O, et al
    Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer.
    PLoS One. 2017;12:e0185436.
    PubMed     Text format     Abstract available


  115. XU R, Lin L, Li Y, Li Y, et al
    ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0185254.
    PubMed     Text format     Abstract available


  116. HILSDEN RJ, Bridges R, Dube C, Heitman SJ, et al
    Scheduling rules for patients with diabetes mellitus that facilitate split-dosing improve the quality of bowel preparation for colonoscopy.
    PLoS One. 2017;12:e0182225.
    PubMed     Text format     Abstract available


  117. HOCHMAN G, Halevi-Tobias K, Kogan Y, Agur Z, et al
    Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model.
    PLoS One. 2017;12:e0179888.
    PubMed     Text format     Abstract available


  118. HENNENBERG EM, Eyking A, Reis H, Cario E, et al
    MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis.
    PLoS One. 2017;12:e0180834.
    PubMed     Text format     Abstract available


  119. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Text format     Abstract available


  120. BLAGOEV KB, Wilkerson J, Burotto M, Kim C, et al
    Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status.
    PLoS One. 2017;12:e0175484.
    PubMed     Text format     Abstract available


  121. CHOI YJ, Lee DH, Han KD, Kim HS, et al
    The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
    PLoS One. 2017;12:e0185778.
    PubMed     Text format     Abstract available


  122. LIN GL, Ting HJ, Tseng TC, Juang V, et al
    Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    PLoS One. 2017;12:e0185625.
    PubMed     Text format     Abstract available


  123. MORUZZI S, Guarini P, Udali S, Ruzzenente A, et al
    One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.
    PLoS One. 2017;12:e0185792.
    PubMed     Text format     Abstract available


  124. TSENG JC, Narayanan N, Ho G, Groves K, et al
    Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
    PLoS One. 2017;12:e0182689.
    PubMed     Text format     Abstract available


  125. LI P, Xiao Z, Braciak TA, Ou Q, et al
    Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.
    PLoS One. 2017;12:e0181615.
    PubMed     Text format     Abstract available


  126. GASLJEVIC G, Edhemovic I, Cemazar M, Brecelj E, et al
    Histopathological findings in colorectal liver metastases after electrochemotherapy.
    PLoS One. 2017;12:e0180709.
    PubMed     Text format     Abstract available


  127. MURPHY C, Rettedal E, Lehouritis P, Devoy C, et al
    Intratumoural production of TNFalpha by bacteria mediates cancer therapy.
    PLoS One. 2017;12:e0180034.
    PubMed     Text format     Abstract available


  128. RIVA A, BOrgesen M, Guldmann-Christensen M, Hauge Kyneb M, et al
    SensiScreen(R)KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.
    PLoS One. 2017;12:e0178027.
    PubMed     Text format     Abstract available


  129. SINN DH, Min YW, Son HJ, Rhee PL, et al
    Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma.
    PLoS One. 2017;12:e0179480.
    PubMed     Text format     Abstract available


  130. JUNG SY, Rohan T, Strickler H, Bea J, et al
    Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
    PLoS One. 2017;12:e0186296.
    PubMed     Text format     Abstract available


  131. LI Y, Li J, Liu H, Liu Y, et al
    Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer.
    PLoS One. 2017;12:e0186530.
    PubMed     Text format     Abstract available


  132. CHEE CG, Kim YH, Lee KH, Lee YJ, et al
    CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis.
    PLoS One. 2017;12:e0182883.
    PubMed     Text format     Abstract available


  133. DIAO R, Mu X, Wang T, Li S, et al
    Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma.
    PLoS One. 2017;12:e0182908.
    PubMed     Text format     Abstract available


  134. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    PubMed     Text format     Abstract available


  135. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    PubMed     Text format     Abstract available


  136. DARLING NJ, Balmanno K, Cook SJ
    ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell death.
    PLoS One. 2017;12:e0184907.
    PubMed     Text format     Abstract available


  137. KAWAKUBO M, Demehri S, Manstein D
    Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.
    PLoS One. 2017;12:e0184852.
    PubMed     Text format     Abstract available


  138. HUANG JY, Wang R, Gao YT, Yuan JM, et al
    ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
    PLoS One. 2017;12:e0184295.
    PubMed     Text format     Abstract available


  139. KUMARASAMY V, Kuppusamy UR, Jayalakshmi P, Samudi C, et al
    Exacerbation of colon carcinogenesis by Blastocystis sp.
    PLoS One. 2017;12:e0183097.
    PubMed     Text format     Abstract available


  140. OLSSON PO, Kalamajski S, Maccarana M, Oldberg A, et al
    Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma.
    PLoS One. 2017;12:e0182973.
    PubMed     Text format     Abstract available


  141. YOKOYAMA S, Takeuchi A, Yamaguchi S, Mitani Y, et al
    Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-Measurement by ELISA.
    PLoS One. 2017;12:e0183337.
    PubMed     Text format     Abstract available


  142. GORFINE M, Berndt SI, Chang-Claude J, Hoffmeister M, et al
    Heritability Estimation using a Regularized Regression Approach (HERRA): Applicable to continuous, dichotomous or age-at-onset outcome.
    PLoS One. 2017;12:e0181269.
    PubMed     Text format     Abstract available


  143. PRABHU VV, Lulla AR, Madhukar NS, Ralff MD, et al
    Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
    PLoS One. 2017;12:e0180541.
    PubMed     Text format     Abstract available


  144. XU Q, Tong JL, Zhang CP, Xiao Q, et al
    miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4.
    PLoS One. 2017;12:e0186718.
    PubMed     Text format     Abstract available


  145. LEI S, Ding Y, Fu Y, Wu S, et al
    The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.
    PLoS One. 2017;12:e0184501.
    PubMed     Text format     Abstract available


  146. PRALL F, Maletzki C, Huhns M, Krohn M, et al
    Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment.
    PLoS One. 2017;12:e0186271.
    PubMed     Text format     Abstract available


  147. JUAREZ M, Egoavil C, Rodriguez-Soler M, Hernandez-Illan E, et al
    KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia.
    PLoS One. 2017;12:e0184937.
    PubMed     Text format     Abstract available


  148. MANIKIS GC, Marias K, Lambregts DMJ, Nikiforaki K, et al
    Diffusion weighted imaging in patients with rectal cancer: Comparison between Gaussian and non-Gaussian models.
    PLoS One. 2017;12:e0184197.
    PubMed     Text format     Abstract available


  149. HONG SN, Son HJ, Choi SK, Chang DK, et al
    A prediction model for advanced colorectal neoplasia in an asymptomatic screening population.
    PLoS One. 2017;12:e0181040.
    PubMed     Text format     Abstract available


  150. SCOTT AJ, Song EK, Bagby S, Purkey A, et al
    Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model.
    PLoS One. 2017;12:e0187173.
    PubMed     Text format     Abstract available


  151. ROSWALL N, Bidstrup PE, Raaschou-Nielsen O, Solvang Jensen S, et al
    Residential road traffic noise exposure and colorectal cancer survival - A Danish cohort study.
    PLoS One. 2017;12:e0187161.
    PubMed     Text format     Abstract available


  152. MYUNG DS, Kweon SS, Lee J, Shin IS, et al
    Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID).
    PLoS One. 2017;12:e0184205.
    PubMed     Text format     Abstract available


  153. BRAND EC, Crook JE, Thomas CS, Siersema PD, et al
    Development and validation of a prediction model for adenoma detection during screening and surveillance colonoscopy with comparison to actual adenoma detection rates.
    PLoS One. 2017;12:e0185560.
    PubMed     Text format     Abstract available


    January 2016
  154. CHEN X, Deane NG, Lewis KB, Li J, et al
    Comparison of Nanostring nCounter(R) Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues.
    PLoS One. 2016;11:e0153784.
    PubMed     Text format     Abstract available


  155. HUO H, Zhou Z, Qin J, Liu W, et al
    Erastin Disrupts Mitochondrial Permeability Transition Pore (mPTP) and Induces Apoptotic Death of Colorectal Cancer Cells.
    PLoS One. 2016;11:e0154605.
    PubMed     Text format     Abstract available


  156. VOGTMANN E, Hua X, Zeller G, Sunagawa S, et al
    Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing.
    PLoS One. 2016;11:e0155362.
    PubMed     Text format     Abstract available


  157. CHOU CK, Chen SL, Yen AM, Chiu SY, et al
    Outreach and Inreach Organized Service Screening Programs for Colorectal Cancer.
    PLoS One. 2016;11:e0155276.
    PubMed     Text format     Abstract available


  158. FOSTER C, Haviland J, Winter J, Grimmett C, et al
    Pre-Surgery Depression and Confidence to Manage Problems Predict Recovery Trajectories of Health and Wellbeing in the First Two Years following Colorectal Cancer: Results from the CREW Cohort Study.
    PLoS One. 2016;11:e0155434.
    PubMed     Text format     Abstract available


  159. BUHL IK, Gerster S, Delorenzi M, Jensen T, et al
    Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data.
    PLoS One. 2016;11:e0155123.
    PubMed     Text format     Abstract available


  160. LI B, Gan A, Chen X, Wang X, et al
    Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.
    PLoS One. 2016;11:e0155095.
    PubMed     Text format     Abstract available


  161. KIM JC, Ha YJ, Tak KH, Roh SA, et al
    Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.
    PLoS One. 2016;11:e0155160.
    PubMed     Text format     Abstract available


  162. AAN DE STEGGE WB, van Leeuwen BL, Elferink MA, de Bock GH, et al
    The Evaluation of More Lymph Nodes in Colon Cancer Is Associated with Improved Survival in Patients of All Ages.
    PLoS One. 2016;11:e0155608.
    PubMed     Text format     Abstract available


  163. VAN HELDEN EJ, Hoekstra OS, Boellaard R, Roth C, et al
    Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
    PLoS One. 2016;11:e0155178.
    PubMed     Text format     Abstract available


  164. GORGES TM, Stein A, Quidde J, Hauch S, et al
    Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch(R) System and the AdnaTest(R).
    PLoS One. 2016;11:e0155126.
    PubMed     Text format     Abstract available


  165. DI CARO G, Carvello M, Pesce S, Erreni M, et al
    Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.
    PLoS One. 2016;11:e0156669.
    PubMed     Text format     Abstract available


  166. HUSSAIN T, Chang HY, Luu NP, Pollack CE, et al
    The Value of Continuity between Primary Care and Surgical Care in Colon Cancer.
    PLoS One. 2016;11:e0155789.
    PubMed     Text format     Abstract available


  167. ADAMS SV, Ceballos R, Newcomb PA
    Quality of Life and Mortality of Long-Term Colorectal Cancer Survivors in the Seattle Colorectal Cancer Family Registry.
    PLoS One. 2016;11:e0156534.
    PubMed     Text format     Abstract available


  168. PALANIAPPAN A, Ramar K, Ramalingam S
    Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression.
    PLoS One. 2016;11:e0156665.
    PubMed     Text format     Abstract available


  169. EYKING A, Reis H, Frank M, Gerken G, et al
    MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer.
    PLoS One. 2016;11:e0156871.
    PubMed     Text format     Abstract available


  170. HAMIDOU Z, Chibaudel B, Hebbar M, Hug de Larauze M, et al
    Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial.
    PLoS One. 2016;11:e0157067.
    PubMed     Text format     Abstract available


  171. ALKHAYAL KA, Awadalia ZH, Vaali-Mohammed MA, Al Obeed OA, et al
    Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population.
    PLoS One. 2016;11:e0155236.
    PubMed     Text format     Abstract available


  172. VELUCHAMY JP, Spanholtz J, Tordoir M, Thijssen VL, et al
    Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.
    PLoS One. 2016;11:e0157830.
    PubMed     Text format     Abstract available


  173. HU S, Zou Z, Li H, Zou G, et al
    The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients.
    PLoS One. 2016;11:e0157486.
    PubMed     Text format     Abstract available


  174. LIN PC, Yang YF, Tyan YC, Hsiao ES, et al
    Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses.
    PLoS One. 2016;11:e0158844.
    PubMed     Text format     Abstract available


  175. NEGM OH, Hamed MR, Schoen RE, Whelan RL, et al
    Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    PLoS One. 2016;11:e0156971.
    PubMed     Text format     Abstract available


  176. GOGOI P, Sepehri S, Zhou Y, Gorin MA, et al
    Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples.
    PLoS One. 2016;11:e0147400.
    PubMed     Text format     Abstract available


  177. NOVESKI P, Madjunkova S, Sukarova Stefanovska E, Matevska Geshkovska N, et al
    Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients.
    PLoS One. 2016;11:e0146264.
    PubMed     Text format     Abstract available


  178. SATO KA, Hachiya T, Iwaya T, Kume K, et al
    Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.
    PLoS One. 2016;11:e0146275.
    PubMed     Text format     Abstract available


  179. TIPTIRI-KOURPETI A, Spyridopoulou K, Santarmaki V, Aindelis G, et al
    Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells.
    PLoS One. 2016;11:e0147960.
    PubMed     Text format     Abstract available


  180. FEIERSINGER F, Nolte E, Wach S, Rau TT, et al
    MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
    PLoS One. 2016;11:e0148580.
    PubMed     Text format     Abstract available


  181. MAIDEN SL, Petrova YI, Gumbiner BM
    Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model.
    PLoS One. 2016;11:e0148574.
    PubMed     Text format     Abstract available


  182. LEE LS, Seng KY, Wang LZ, Yong WP, et al
    Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI.
    PLoS One. 2016;11:e0147681.
    PubMed     Text format     Abstract available


  183. CEA SORIANO L, Soriano-Gabarro M, Garcia Rodriguez LA
    The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice.
    PLoS One. 2016;11:e0159179.
    PubMed     Text format     Abstract available


  184. TAKAYA A, Hirohashi Y, Murai A, Morita R, et al
    Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
    PLoS One. 2016;11:e0158903.
    PubMed     Text format     Abstract available


  185. PHANG CW, Karsani SA, Sethi G, Abd Malek SN, et al
    Flavokawain C Inhibits Cell Cycle and Promotes Apoptosis, Associated with Endoplasmic Reticulum Stress and Regulation of MAPKs and Akt Signaling Pathways in HCT 116 Human Colon Carcinoma Cells.
    PLoS One. 2016;11:e0148775.
    PubMed     Text format     Abstract available


  186. REYES-ZURITA FJ, Rufino-Palomares EE, Garcia-Salguero L, Peragon J, et al
    Maslinic Acid, a Natural Triterpene, Induces a Death Receptor-Mediated Apoptotic Mechanism in Caco-2 p53-Deficient Colon Adenocarcinoma Cells.
    PLoS One. 2016;11:e0146178.
    PubMed     Text format     Abstract available


  187. JIMENEZ S, Gascon S, Luquin A, Laguna M, et al
    Rosa canina Extracts Have Antiproliferative and Antioxidant Effects on Caco-2 Human Colon Cancer.
    PLoS One. 2016;11:e0159136.
    PubMed     Text format     Abstract available


  188. ZHOU J, Chang L, Guan Y, Yang L, et al
    Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.
    PLoS One. 2016;11:e0159708.
    PubMed     Text format     Abstract available


  189. KIM SH, Park YY, Cho SN, Margalit O, et al
    Kruppel-Like Factor 12 Promotes Colorectal Cancer Growth through Early Growth Response Protein 1.
    PLoS One. 2016;11:e0159899.
    PubMed     Text format     Abstract available


  190. GRANDE R, Natoli C, Ciancola F, Gemma D, et al
    Treatment of Metastatic Colorectal Cancer Patients >/=75 Years Old in Clinical Practice: A Multicenter Analysis.
    PLoS One. 2016;11:e0157751.
    PubMed     Text format     Abstract available


  191. COSTA-CABRAL S, Brough R, Konde A, Aarts M, et al
    CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
    PLoS One. 2016;11:e0149099.
    PubMed     Text format     Abstract available


  192. KUAN CS, See Too WC, Few LL
    Sp1 and Sp3 Are the Transcription Activators of Human ek1 Promoter in TSA-Treated Human Colon Carcinoma Cells.
    PLoS One. 2016;11:e0147886.
    PubMed     Text format     Abstract available


  193. SETH C, Ruiz I Altaba A
    Correction: Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.
    PLoS One. 2016;11:e0160904.
    PubMed     Text format     Abstract available


  194. CHEN W, Li Q, Fan Y, Li D, et al
    Factors Predicting Difficulty of Laparoscopic Low Anterior Resection for Rectal Cancer with Total Mesorectal Excision and Double Stapling Technique.
    PLoS One. 2016;11:e0151773.
    PubMed     Text format     Abstract available


  195. NAM SK, Yun S, Koh J, Kwak Y, et al
    BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
    PLoS One. 2016;11:e0151865.
    PubMed     Text format     Abstract available


  196. ERIKSEN AH, Andersen RF, Pallisgaard N, Sorensen FB, et al
    MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
    PLoS One. 2016;11:e0150593.
    PubMed     Text format     Abstract available


  197. MARTINO-ECHARRI E, Brocardo MG, Mills KM, Henderson BR, et al
    Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of beta-Catenin Degradation-Competent Axin Puncta.
    PLoS One. 2016;11:e0150484.
    PubMed     Text format     Abstract available


  198. PINTO AT, Pinto ML, Velho S, Pinto MT, et al
    Intricate Macrophage-Colorectal Cancer Cell Communication in Response to Radiation.
    PLoS One. 2016;11:e0160891.
    PubMed     Text format     Abstract available


  199. CHANG YJ, Cheng YW, Lin RK, Huang CC, et al
    Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).
    PLoS One. 2016;11:e0160550.
    PubMed     Text format     Abstract available


  200. KANG MR, Park KH, Yang JO, Lee CW, et al
    miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells.
    PLoS One. 2016;11:e0160961.
    PubMed     Text format     Abstract available


  201. JI K, Zhang M, Chu Q, Gan Y, et al
    The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0160125.
    PubMed     Text format     Abstract available


  202. NANDA N, Dhawan DK, Bhatia A, Mahmood A, et al
    Doxycycline Promotes Carcinogenesis & Metastasis via Chronic Inflammatory Pathway: An In Vivo Approach.
    PLoS One. 2016;11:e0151539.
    PubMed     Text format     Abstract available


  203. CHEN JY, Tsai WS, Shao HJ, Wu JC, et al
    Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection.
    PLoS One. 2016;11:e0149633.
    PubMed     Text format     Abstract available


  204. ZHANG J, Yi M, Zha L, Chen S, et al
    Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis.
    PLoS One. 2016;11:e0147218.
    PubMed     Text format     Abstract available


  205. KIM H, Myoung S, Koom WS, Kim NK, et al
    MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.
    PLoS One. 2016;11:e0146235.
    PubMed     Text format     Abstract available


  206. YAN H, Hu K, Wu W, Li Y, et al
    Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
    PLoS One. 2016;11:e0159954.
    PubMed     Text format     Abstract available


  207. SONG LP, Wang HY
    Modeling and Control of Colorectal Cancer.
    PLoS One. 2016;11:e0161349.
    PubMed     Text format     Abstract available


  208. JO P, Konig A, Schirmer M, Kitz J, et al
    Heterogeneity of KRAS Mutation Status in Rectal Cancer.
    PLoS One. 2016;11:e0153278.
    PubMed     Text format     Abstract available


  209. OKERBERG ES, Hainley A, Brown H, Aban A, et al
    Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1alpha by Chemical Proteomics.
    PLoS One. 2016;11:e0152934.
    PubMed     Text format     Abstract available


  210. BAJENOVA O, Gorbunova A, Evsyukov I, Rayko M, et al
    The Genome-Wide Analysis of Carcinoembryonic Antigen Signaling by Colorectal Cancer Cells Using RNA Sequencing.
    PLoS One. 2016;11:e0161256.
    PubMed     Text format     Abstract available


  211. ILIC I, Jankovic S, Ilic M
    Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.
    PLoS One. 2016;11:e0161912.
    PubMed     Text format     Abstract available


  212. CHEN YG, Chen MQ, Guo YY, Li SC, et al
    Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    PLoS One. 2016;11:e0153944.
    PubMed     Text format     Abstract available


  213. SUNDSTROM A, Grabocka E, Bar-Sagi D, Mishra B, et al
    Histological Image Processing Features Induce a Quantitative Characterization of Chronic Tumor Hypoxia.
    PLoS One. 2016;11:e0153623.
    PubMed     Text format     Abstract available


  214. ABULI A, Castells A, Bujanda L, Lozano JJ, et al
    Genetic Variants Associated with Colorectal Adenoma Susceptibility.
    PLoS One. 2016;11:e0153084.
    PubMed     Text format     Abstract available


  215. ISSOP L, Ostuni MA, Lee S, Laforge M, et al
    Translocator Protein-Mediated Stabilization of Mitochondrial Architecture during Inflammation Stress in Colonic Cells.
    PLoS One. 2016;11:e0152919.
    PubMed     Text format     Abstract available


  216. MILLER CL, Muthupalani S, Shen Z, Drees F, et al
    Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma.
    PLoS One. 2016;11:e0152940.
    PubMed     Text format     Abstract available


  217. HASEGAWA K, Saiura A, Takayama T, Miyagawa S, et al
    Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
    PLoS One. 2016;11:e0162400.
    PubMed     Text format     Abstract available


  218. FALCONE E, Grandoni L, Garibaldi F, Manni I, et al
    Infinity: An In-Silico Tool for Genome-Wide Prediction of Specific DNA Matrices in miRNA Genomic Loci.
    PLoS One. 2016;11:e0153658.
    PubMed     Text format     Abstract available


  219. CATALAN V, Gomez-Ambrosi J, Rodriguez A, Ramirez B, et al
    Increased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon Cancer.
    PLoS One. 2016;11:e0162189.
    PubMed     Text format     Abstract available


  220. CHEN J, Raju GS, Jogunoori W, Menon V, et al
    Mutational Profiles Reveal an Aberrant TGF-beta-CEA Regulated Pathway in Colon Adenomas.
    PLoS One. 2016;11:e0153933.
    PubMed     Text format     Abstract available


  221. GU X, Gao XS, Qin S, Li X, et al
    Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.
    PLoS One. 2016;11:e0163523.
    PubMed     Text format     Abstract available


  222. BOTTICELLI A, Borro M, Onesti CE, Strigari L, et al
    Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?
    PLoS One. 2016;11:e0163105.
    PubMed     Text format     Abstract available


  223. TSUKIHARA H, Tsunekuni K, Takechi T
    Folic Acid-Metabolizing Enzymes Regulate the Antitumor Effect of 5-Fluoro-2'-Deoxyuridine in Colorectal Cancer Cell Lines.
    PLoS One. 2016;11:e0163961.
    PubMed     Text format     Abstract available


  224. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
    Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    PLoS One. 2016;11:e0163209.
    PubMed     Text format     Abstract available


  225. SOLASSOL J, Vendrell J, Markl B, Haas C, et al
    Multi-Center Evaluation of the Fully Automated PCR-Based Idylla KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
    PLoS One. 2016;11:e0163444.
    PubMed     Text format     Abstract available


  226. HUANG WS, Hsieh MC, Huang CY, Kuo YH, et al
    The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells.
    PLoS One. 2016;11:e0159927.
    PubMed     Text format     Abstract available


  227. CHANG YT, Huang MY, Yeh YS, Huang CW, et al
    A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
    PLoS One. 2016;11:e0163264.
    PubMed     Text format     Abstract available


  228. BUDHATHOKI S, Yamaji T, Iwasaki M, Sawada N, et al
    Vitamin D Receptor Gene Polymorphism and the Risk of Colorectal Cancer: A Nested Case-Control Study.
    PLoS One. 2016;11:e0164648.
    PubMed     Text format     Abstract available


  229. COMAS M, Mendivil J, Andreu M, Hernandez C, et al
    Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program.
    PLoS One. 2016;11:e0164666.
    PubMed     Text format     Abstract available


  230. SUN X, Hu Y, Zhang L, Hu C, et al
    Mining, Validation, and Clinical Significance of Colorectal Cancer (CRC)-Associated lncRNAs.
    PLoS One. 2016;11:e0164590.
    PubMed     Text format     Abstract available


  231. LOPE V, Fernandez de Larrea N, Perez-Gomez B, Martin V, et al
    Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.
    PLoS One. 2016;11:e0164620.
    PubMed     Text format     Abstract available


  232. LIN J, Hiraoka K, Watanabe T, Kuo T, et al
    Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
    PLoS One. 2016;11:e0165581.
    PubMed     Text format     Abstract available


  233. IGUCHI T, Nambara S, Masuda T, Komatsu H, et al
    miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis.
    PLoS One. 2016;11:e0165912.
    PubMed     Text format     Abstract available


  234. LENNARD KS, Goosen RW, Blackburn JM
    Bacterially-Associated Transcriptional Remodelling in a Distinct Genomic Subtype of Colorectal Cancer Provides a Plausible Molecular Basis for Disease Development.
    PLoS One. 2016;11:e0166282.
    PubMed     Text format     Abstract available


  235. MIGUCHI M, Hinoi T, Shimomura M, Adachi T, et al
    Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    PLoS One. 2016;11:e0166422.
    PubMed     Text format     Abstract available


  236. KAMIZA AB, Hsieh LL, Tang R, Chien HT, et al
    TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
    PLoS One. 2016;11:e0167354.
    PubMed     Text format     Abstract available


  237. YAP R, Wilkins S, Staples M, Oliva K, et al
    The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients.
    PLoS One. 2016;11:e0167271.
    PubMed     Text format     Abstract available


  238. CHANDLER PD, Akinkuolie AO, Tobias DK, Lawler PR, et al
    Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality.
    PLoS One. 2016;11:e0165615.
    PubMed     Text format     Abstract available


  239. ALAJEZ NM
    Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
    PLoS One. 2016;11:e0167455.
    PubMed     Text format     Abstract available


  240. TOMINAGA T, Nonaka T, Sumida Y, Hidaka S, et al
    The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients.
    PLoS One. 2016;11:e0167967.
    PubMed     Text format     Abstract available


  241. KAI M, Niinuma T, Kitajima H, Yamamoto E, et al
    TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
    PLoS One. 2016;11:e0168281.
    PubMed     Text format     Abstract available


  242. RAMAKER K, Bade S, Rockendorf N, Meckelein B, et al
    Absence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal Cancer.
    PLoS One. 2016;11:e0168801.
    PubMed     Text format     Abstract available


  243. ZHANG ZY, Li C, Gao W, Yin XW, et al
    A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer.
    PLoS One. 2016;11:e0168156.
    PubMed     Text format     Abstract available


  244. VARGAS T, Moreno-Rubio J, Herranz J, Cejas P, et al
    3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients.
    PLoS One. 2016;11:e0168423.
    PubMed     Text format     Abstract available


  245. MULLINS CS, Huhns M, Krohn M, Peters S, et al
    Generation, Characterization and Application of Antibodies Directed against HERV-H Gag Protein in Colorectal Samples.
    PLoS One. 2016;11:e0153349.
    PubMed     Text format     Abstract available


  246. WANG X, Ji P, Zhang Y, LaComb JF, et al
    Aberrant DNA Methylation: Implications in Racial Health Disparity.
    PLoS One. 2016;11:e0153125.
    PubMed     Text format     Abstract available


  247. GALISSIER T, Schneider C, Nasri S, Kanagaratnam L, et al
    Biobanking of Fresh-Frozen Human Adenocarcinomatous and Normal Colon Tissues: Which Parameters Influence RNA Quality?
    PLoS One. 2016;11:e0154326.
    PubMed     Text format     Abstract available


  248. BHARDWAJ M, Kim NH, Paul S, Jakhar R, et al
    5-Hydroxy-7-Methoxyflavone Triggers Mitochondrial-Associated Cell Death via Reactive Oxygen Species Signaling in Human Colon Carcinoma Cells.
    PLoS One. 2016;11:e0154525.
    PubMed     Text format     Abstract available


  249. CARCHMAN EH, Matkowskyj KA, Meske L, Lambert PF, et al
    Dysregulation of Autophagy Contributes to Anal Carcinogenesis.
    PLoS One. 2016;11:e0164273.
    PubMed     Text format     Abstract available


  250. PAN CH, Chang CC, Su CT, Tsai PS, et al
    Trends in Irritable Bowel Syndrome Incidence among Taiwanese Adults during 2003-2013: A Population-Based Study of Sex and Age Differences.
    PLoS One. 2016;11:e0166922.
    PubMed     Text format     Abstract available


  251. KUNISAWA S, Fushimi K, Imanaka Y
    Reducing Length of Hospital Stay Does Not Increase Readmission Rates in Early-Stage Gastric, Colon, and Lung Cancer Surgical Cases in Japanese Acute Care Hospitals.
    PLoS One. 2016;11:e0166269.
    PubMed     Text format     Abstract available


  252. MASOOMPOUR SM, Lankarani KB, Honarvar B, Tabatabaee SH, et al
    Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.
    PLoS One. 2016;11:e0155669.
    PubMed     Text format     Abstract available


    January 2015
  253. CHEN LX, Ning GZ, Zhou ZR, Li YL, et al
    The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies.
    PLoS One. 2015;10:e0123080.
    PubMed     Text format     Abstract available


  254. MBANG PA, Kowalkowski MA, Amirian ES, Giordano TP, et al
    Association between Time on Protease Inhibitors and the Incidence of Squamous Cell Carcinoma of the Anus among U.S. Male Veterans.
    PLoS One. 2015;10:e0142966.
    PubMed     Text format     Abstract available


  255. YING J, Lin C, Wu J, Guo L, et al
    Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population.
    PLoS One. 2015;10:e0144731.
    PubMed     Text format     Abstract available


  256. CHATTOPADHYAY N, Berger AJ, Koenig E, Bannerman B, et al
    KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
    PLoS One. 2015;10:e0144825.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: